(Total Views: 582)
Posted On: 01/12/2022 11:02:39 AM
Post# of 153940
Interesting viewpoint, from Dr D, on YMB:
drD32 minutes ago
"One thing is very clear about this molecule : BP understands it’s value quite well especially in cancer . It’s not an adjunct therapy or a synergistic therapy. It’s monotherapy and prevention therapy . Now that is a real existential threat to their existence as all of their chemo drugs increase CCR5 overexpression while Leronlimab stops it . After observing the results of Leronlimab for the past 6 months I can understand why they want to crush the company since Dr NP will not sell it to them . I think the moment he said 3 digits was the moment he took them on. And the war officially started that day ."
drD32 minutes ago
"One thing is very clear about this molecule : BP understands it’s value quite well especially in cancer . It’s not an adjunct therapy or a synergistic therapy. It’s monotherapy and prevention therapy . Now that is a real existential threat to their existence as all of their chemo drugs increase CCR5 overexpression while Leronlimab stops it . After observing the results of Leronlimab for the past 6 months I can understand why they want to crush the company since Dr NP will not sell it to them . I think the moment he said 3 digits was the moment he took them on. And the war officially started that day ."
(7)
(0)
